CASSIDY JAMES enters SPRINGWORKS THERAPEUTICS, INC. with 25.83K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/11/2022ACC: 0001104659-22-107704
Officer· Chief Medical Officer
Since Oct 2022
25.83K
Baseline shares
100% direct
25.83K
Direct ownership
1 position
111.57K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned25.83K
Total
25.83K direct25.83K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25.83K | Direct |
| Total | 25.83K | 25.83K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
32.57K
Shares owned
N/A
Exercise price
59.46
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
79K
Shares owned
N/A
Exercise price
76.30
Expiration
—
Exercise window
—
Total
Underlying
111.57K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 59.46 | — | — | 32.57K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 76.30 | — | — | 79K | N/A |
| Total | 111.57K | 0.00 | ||||